MedPath

Fudan University

Fudan University logo
🇨🇳China
Ownership
Private
Established
1905-01-01
Employees
1K
Market Cap
-
Website
http://www.fudan.edu.cn

A Clinical Study of Children With Status Epilepticus in China

Conditions
Status Epilepticus
First Posted Date
2017-12-20
Last Posted Date
2017-12-20
Lead Sponsor
Fudan University
Target Recruit Count
6000
Registration Number
NCT03378687
Locations
🇨🇳

Beijing Children's Hospital, Beijing, Beijing, China

Chidamide Combined With R-GDP in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)

Phase 2
Conditions
Chidamide
Lymphoma, B-Cell
Lymphoma, Large B-Cell, Diffuse
Neoplasm by Histology
Neoplasms
Lymphoproliferative Disorders
Lymphatic Diseases
Immunoproliferative Disorders
Immune System Diseases
Lymphoma, Non-Hodgkin
Interventions
First Posted Date
2017-12-14
Last Posted Date
2017-12-14
Lead Sponsor
Fudan University
Target Recruit Count
63
Registration Number
NCT03373019
Locations
🇨🇳

Kai Xue, Shanghai, China

Study on the Brain Network of Angelman Syndrome

Completed
Conditions
Angelman Syndrome
First Posted Date
2017-12-02
Last Posted Date
2021-04-26
Lead Sponsor
Fudan University
Target Recruit Count
150
Registration Number
NCT03358823
Locations
🇨🇳

Children's Hospital of Fudan University, Shanghai, Shanghai, China

Omics-based Precision Medicine of Epilepsy

Conditions
Gene Mutation
Epilepsy Idiopathic
Clinical Disease and/or Syndrome
Interventions
Other: non
First Posted Date
2017-11-30
Last Posted Date
2017-11-30
Lead Sponsor
Fudan University
Target Recruit Count
10000
Registration Number
NCT03358459
Locations
🇨🇳

Children's Hospital of Fudan University, Shanghai, Shanghai, China

Simplification and Implementation of Awake Fibreoptic Orotracheal Intubation

Completed
Conditions
Anesthesia
Intubation
Trachea
First Posted Date
2017-11-17
Last Posted Date
2019-01-25
Lead Sponsor
Fudan University
Target Recruit Count
40
Registration Number
NCT03343496
Locations
🇨🇳

Zhongshan hospital, Fudan University, Shanghai, Shanghai, China

Thalidomide Combined With R-CHOP in Newly Diagnosed,Untreated Double-expressor Diffuse Large B-Cell Lymphoma Patients

Phase 3
Conditions
Thalidomide
Interventions
First Posted Date
2017-10-24
Last Posted Date
2017-10-24
Lead Sponsor
Fudan University
Target Recruit Count
162
Registration Number
NCT03318835
Locations
🇨🇳

Fudan University Cancer Hospital, Shanghai, Shanghai, China

Peritoneal Lavage for Early Detecting Gene Mutation of Peritoneal Metastasis of Gastric Cancer

Completed
Conditions
Gastric Cancer
Interventions
Other: Observational study
First Posted Date
2017-10-19
Last Posted Date
2019-05-08
Lead Sponsor
Fudan University
Target Recruit Count
200
Registration Number
NCT03314649
Locations
🇨🇳

Cancer Center of Sun Yat-sen University, Guangzhou, Guangdong, China

Selective Pelvic Lymphadenectomy for IB-IIA Cervical Cancer

Phase 2
Conditions
Cervical Cancer
Interventions
Procedure: Lymph nodes debulking surgery.
First Posted Date
2017-09-28
Last Posted Date
2020-08-19
Lead Sponsor
Fudan University
Target Recruit Count
200
Registration Number
NCT03295526
Locations
🇨🇳

Fudan university, Shanghai, Shanghai, China

Analysis of Nutrition During Chemoradiotherapy in Patients With Gastrointestinal Cancer

Conditions
Chemoradiotherapy
Nutritional Status
Gastrointestinal Cancer
First Posted Date
2017-09-18
Last Posted Date
2017-09-18
Lead Sponsor
Fudan University
Target Recruit Count
500
Registration Number
NCT03286348
Locations
🇨🇳

Zhen Zhang, Shanghai, Shanghai, China

Tissue-of-origin Directing Therapy in Patients With Cancer of Unknown Primary

Phase 3
Completed
Conditions
Cancer of Unknown Primary Site
Interventions
Genetic: tissue-of-origin (ORIGIN-PanCA○R) profiling
First Posted Date
2017-09-11
Last Posted Date
2022-01-24
Lead Sponsor
Fudan University
Target Recruit Count
182
Registration Number
NCT03278600
Locations
🇨🇳

Fudan University Cancer Hospital, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath